Health Trials

Kras G12c Positive Advanced Or Metastatic Non Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

1

Review clinical trials related to Kras G12c Positive Advanced Or Metastatic Non Small Cell Lung Cancer Patients Who Have Failed Standard Treatment. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

The study is being conducted to evaluate the efficacy, and safety of HRS-7058 in KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

Participants needed: 450
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: Shandong Suncadia Medicine Co., Ltd.Updated: May 22, 2026Locations: 1
Eligibility criteria

Age 18 years old to 75 years old ( including both ends ), regardless of gender ; [+8]

Subjects with active central nervous system ( CNS ) metastasis ; [+9]

Read more